RXYLT1 and carcinoma: This gene encodes a type II membrane protein that is a member of the glycosyltransferase family, is known to be a breast cancer biomarker that is associated with carcinoma differentiation [32], drug resistance [33], and tumor-associated carbohydrate antigens (TACA) in breast cancer [34].